Literature DB >> 7083458

VM26 therapy in children with drug-refractory lymphocytic leukemia.

G Rivera, G V Dahl, S B Murphy, W P Bowman, R J Aur, T L Avery, J V Simone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7083458     DOI： 10.1007/BF00254541

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  16 in total

1.  Effects of the epipodophyllotoxin derivative VM 26 in mitosis and in interphase.

Authors:  H Stähelin; G Poschmann
Journal:  Oncology       Date:  1978       Impact factor: 2.935

2.  Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.

Authors:  G Rivera; T Avery; D W Roberts
Journal:  Eur J Cancer       Date:  1975-09       Impact factor: 9.162

3.  Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.

Authors:  C Tan; H Tasaka; K P Yu; M L Murphy; D A Karnofsky
Journal:  Cancer       Date:  1967-03       Impact factor: 6.860

4.  Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.

Authors:  P Dombernowsky; N I Nissen; V Larsen
Journal:  Cancer Chemother Rep       Date:  1972-02

5.  Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL).

Authors:  J M Chessells; M Cornbleet
Journal:  Med Pediatr Oncol       Date:  1979

6.  Poor outlook for childhood acute lymphoblastic leukaemia with relapse.

Authors:  H Ekert; W M Ellis; K D Waters; R N Matthews
Journal:  Med J Aust       Date:  1979-09-08       Impact factor: 7.738

Review 7.  Childhood acute lymphocytic leukemia: progress and problems in treatment.

Authors:  W P Bowman
Journal:  Can Med Assoc J       Date:  1981-01-15       Impact factor: 8.262

8.  VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.

Authors:  G Rivera; G V Dahl; W P Bowman; T L Avery; A Wood; R J Aur
Journal:  Cancer       Date:  1980-10-15       Impact factor: 6.860

9.  [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].

Authors:  G Mathé; L Schwarzenberg; P Pouillart; R Weiner; R Oldham; C Jasmin; M Hayat; M Schneider; J L Amiel; B Céoara; M Steresco-Musset; F de Vassal
Journal:  Nouv Presse Med       Date:  1974-02-23

10.  Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.

Authors:  A Krishan; K Paika; E Frei
Journal:  J Cell Biol       Date:  1975-09       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.